O(6)-Benzylguanine in Treating Patients With Malignant Glioma

NCT00002971 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: O6-benzylguanine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]